ICD-10 Uptake Poll: Week 1

Poll

You knew it was coming; you prepared and prepared; you had meetings, you stayed late; you were ready. So, how'd it go?

How has your practice managed during the first week of ICD-10 implementation?

©opicobello/Shutterstock.com

 

A. Better than we expected
B. Worse than we expected
C. Pretty much as we expected
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
RAD 2025: What You May Have Missed

RAD 2025: What You May Have Missed

Sydney Jennings
June 13th 2025
Article

Explore key insights from the 2025 Revolutionizing Atopic Dermatitis meeting, featuring expert interviews and the latest treatment advancements.

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Sydney Jennings
June 11th 2025
Podcast

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

Novo Nordisk Advances Amycretin SC and Oral into Phase 3 Development for Weight Management /image credit ©Remigiusz Góra/stock.adobe.com

Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity

Grace Halsey
June 13th 2025
Article

Both oral and subcutaneous formulations of the long-acting GLP-1 and amylin receptor agonist move into stage 3 clinical trials following positive feedback from regulators.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose / image credit: ©New Africa/AdobeStock

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose

Sydney Jennings
June 13th 2025
Article

Your daily dose of the clinical news you may have missed.

Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MD

Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MD

Leon Kircik, MD ;Grace Halsey
June 13th 2025
Article

RAD 2025: Renowned AD investigator Kircik provides the history behind the class-wide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.

© 2025 MJH Life Sciences

All rights reserved.